• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

是否到了重新评估α-硫辛酸和烟酰胺治疗精神分裂症的时候了?

Is it time to reassess alpha lipoic acid and niacinamide therapy in schizophrenia?

机构信息

Department of Kinesiology and Human Nutrition, University of Illinois at Chicago, 1919 Taylor, Chicago, IL 60612, USA.

出版信息

Med Hypotheses. 2010 Dec;75(6):572-5. doi: 10.1016/j.mehy.2010.07.034. Epub 2010 Aug 12.

DOI:10.1016/j.mehy.2010.07.034
PMID:20708342
Abstract

As sulfur containing thiols, alpha lipoic acid (ALA) and its reduced form dihydrolipoic acid (DHLA) are powerful antioxidants and free radical scavengers capable of performing many of the same functions as glutathione (GSH). ALA supplementation may help protect mitochondria from oxidative stress, a possible mechanism contributing to certain forms of brain diseases called schizophrenia. Shortly before the advent of antipsychotic medications, two small studies found ALA relieved psychiatric symptoms in schizophrenia. More recently, animal studies have shown ALA augmentation improves mitochondrial function. At pharmaceutical levels, niacinamide helps preserve mitochondrial membrane integrity and acts as an antioxidant. ALA is a precursor for lipoamide, an essential mitochondrial coenzyme and niacinamide is a component of niacinamide adenine dinucleotide (NAD). NADH, the reduced form of NAD, is involved in the reduction of ALA to DHLA within the mitochondria. This is relevant to contemporary research because DHLA increases GSH and low GSH levels contribute to mitochondrial dysfunction and oxidative stress which have been implicated in the pathophysiology of schizophrenia.

摘要

作为含硫巯基的物质,α-硫辛酸(ALA)及其还原形式二氢硫辛酸(DHLA)是强大的抗氧化剂和自由基清除剂,能够发挥谷胱甘肽(GSH)的许多相同功能。ALA 补充剂可能有助于保护线粒体免受氧化应激,这可能是导致某些称为精神分裂症的脑疾病的一种机制。在出现抗精神病药物之前不久,两项小型研究发现 ALA 缓解了精神分裂症的精神症状。最近,动物研究表明 ALA 增强可以改善线粒体功能。在药物水平上,烟酰胺有助于维持线粒体膜的完整性,并具有抗氧化作用。ALA 是脂酰基辅酶 A 的前体,脂酰基辅酶 A 是一种必需的线粒体辅酶,而烟酰胺是烟酰胺腺嘌呤二核苷酸(NAD)的组成部分。NADH 是 NAD 的还原形式,参与在线粒体中将 ALA 还原为 DHLA。这与当代研究相关,因为 DHLA 增加了 GSH,而 GSH 水平低会导致线粒体功能障碍和氧化应激,这与精神分裂症的病理生理学有关。

相似文献

1
Is it time to reassess alpha lipoic acid and niacinamide therapy in schizophrenia?是否到了重新评估α-硫辛酸和烟酰胺治疗精神分裂症的时候了?
Med Hypotheses. 2010 Dec;75(6):572-5. doi: 10.1016/j.mehy.2010.07.034. Epub 2010 Aug 12.
2
alpha-Lipoic acid induces apoptosis in human colon cancer cells by increasing mitochondrial respiration with a concomitant O2-*-generation.α-硫辛酸通过增加线粒体呼吸并伴随超氧阴离子生成来诱导人结肠癌细胞凋亡。
Apoptosis. 2005 Mar;10(2):359-68. doi: 10.1007/s10495-005-0810-x.
3
Lipoic acid as a novel treatment for Alzheimer's disease and related dementias.硫辛酸作为治疗阿尔茨海默病及相关痴呆症的新方法。
Pharmacol Ther. 2007 Jan;113(1):154-64. doi: 10.1016/j.pharmthera.2006.07.001. Epub 2006 Sep 20.
4
Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: Participation of antioxidant, nitrergic and neurotrophic mechanisms.单独使用α-硫辛酸以及与氯氮平联合使用可逆转氯胺酮诱导的小鼠精神分裂症样症状:抗氧化、一氧化氮能和神经营养机制的参与
Schizophr Res. 2015 Jul;165(2-3):163-70. doi: 10.1016/j.schres.2015.04.017. Epub 2015 Apr 30.
5
Cardioprotective effects of dihydrolipoic acid and tocopherol in right heart hypertrophy during oxidative stress.二氢硫辛酸和生育酚在氧化应激期间对右心室肥厚的心脏保护作用。
Arzneimittelforschung. 1998 Jan;48(1):13-21.
6
[An endogenous dithiol with antioxidant properties: alpha-lipoic acid, potential uses in cardiovascular diseases].[一种具有抗氧化特性的内源性二硫醇:α-硫辛酸,在心血管疾病中的潜在用途]
Ann Cardiol Angeiol (Paris). 2008 Jun;57(3):161-5. doi: 10.1016/j.ancard.2008.02.018. Epub 2008 Jun 4.
7
α-Lipoic acid has anti-inflammatory and anti-oxidative properties: an experimental study in rats with carrageenan-induced acute and cotton pellet-induced chronic inflammations.α-硫辛酸具有抗炎和抗氧化特性:在角叉菜胶诱导的急性和棉绒球诱导的慢性炎症的大鼠实验研究中。
Br J Nutr. 2011 Jan;105(1):31-43. doi: 10.1017/S0007114510003107. Epub 2010 Nov 15.
8
Antioxidant properties of an endogenous thiol: Alpha-lipoic acid, useful in the prevention of cardiovascular diseases.内源性巯基的抗氧化特性:硫辛酸,可用于预防心血管疾病。
J Cardiovasc Pharmacol. 2009 Nov;54(5):391-8. doi: 10.1097/fjc.0b013e3181be7554.
9
Influence of treatment of diabetic rats with combinations of pycnogenol, beta-carotene, and alpha-lipoic acid on parameters of oxidative stress.碧萝芷、β-胡萝卜素和α-硫辛酸联合治疗对糖尿病大鼠氧化应激参数的影响
J Biochem Mol Toxicol. 2004;18(6):345-52. doi: 10.1002/jbt.20046.
10
Alpha-lipoic acid modulates gut inflammation induced by trinitrobenzene sulfonic acid in rats.α-硫辛酸调节大鼠三硝基苯磺酸诱导的肠道炎症。
J Gastroenterol Hepatol. 2007 Nov;22(11):1859-65. doi: 10.1111/j.1440-1746.2006.04504.x.

引用本文的文献

1
Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment.氧化和线粒体功能障碍框架下的精神分裂症突触病理学与抗精神病治疗:临床与治疗的转化要点
Antioxidants (Basel). 2023 Apr 21;12(4):975. doi: 10.3390/antiox12040975.
2
Comparative metabolomics study on therapeutic mechanism of electro-acupuncture and moxibustion on rats with chronic atrophic gastritis (CAG).电针与艾灸治疗慢性萎缩性胃炎大鼠的比较代谢组学研究
Sci Rep. 2017 Oct 30;7(1):14362. doi: 10.1038/s41598-017-13195-5.
3
Nutritional interventions for the adjunctive treatment of schizophrenia: a brief review.
精神分裂症辅助治疗的营养干预:简要综述
Nutr J. 2014 Sep 16;13:91. doi: 10.1186/1475-2891-13-91.
4
Glutathione metabolism enzymes in brain and liver of hyperphenylalaninemic rats and the effect of lipoic acid treatment.高苯丙氨酸血症大鼠脑和肝脏中的谷胱甘肽代谢酶以及硫辛酸治疗的效果
Metab Brain Dis. 2014 Sep;29(3):609-15. doi: 10.1007/s11011-014-9491-x. Epub 2014 Feb 2.
5
Molecular links between mitochondrial dysfunctions and schizophrenia.线粒体功能障碍与精神分裂症之间的分子联系。
Mol Cells. 2012 Feb;33(2):105-10. doi: 10.1007/s10059-012-2284-3. Epub 2012 Feb 15.
6
Oxidative stress in schizophrenia: an integrated approach.精神分裂症中的氧化应激:一种综合方法。
Neurosci Biobehav Rev. 2011 Jan;35(3):878-93. doi: 10.1016/j.neubiorev.2010.10.008. Epub 2010 Oct 23.